Cargando…
Identification of Mannich Base as a Novel Inhibitor of Mycobacterium Tuberculosis Isocitrate by High-Throughput Screening
Mycobacterium tuberculosis (MTB) remains one of the most significant human pathogens since its discovery in 1882. An estimated 1.5 million people died from tubercle bacillus (TB) in 2006, and globally, there were an estimated 9.27 million incident cases of TB in 2007. Glyoxylate bypass pathway occur...
Autores principales: | Ji, Lei, Long, Quanxin, Yang, Dacheng, Xie, Jianping |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076504/ https://www.ncbi.nlm.nih.gov/pubmed/21494431 |
Ejemplares similares
-
Discovery of a Novel Inhibitor Structure of Mycobacterium tuberculosis Isocitrate Lyase
por: Duan, Changyuan, et al.
Publicado: (2022) -
Potential Inhibitors for Isocitrate Lyase of Mycobacterium tuberculosis and Non-M. tuberculosis: A Summary
por: Lee, Yie-Vern, et al.
Publicado: (2015) -
Identification of Concomitant Inhibitors against Glutamine Synthetase and Isocitrate Lyase in Mycobacterium tuberculosis from Natural Sources
por: Chanda, Anesha, et al.
Publicado: (2022) -
Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase
por: Ibeji, Collins U., et al.
Publicado: (2020) -
Development of NMR and thermal shift assays for the evaluation of Mycobacterium tuberculosis isocitrate lyase inhibitors
por: Bhusal, Ram Prasad, et al.
Publicado: (2017)